Breaking news in spinal cord injury research: FDA approved phase I clinical trial of human, autologous schwann cell transplantation in patients with spinal cord injuries

Xu, Xiao-Ming2016-06-272016-06-272012-08-05Xu, X.-M. (2012). Breaking News in Spinal Cord Injury Research: FDA Approved Phase I Clinical Trial of Human, Autologous Schwann Cell Transplantation in Patients with Spinal Cord Injuries. Neural Regeneration Research, 7(22), 1685–1687. http://doi.org/10.3969/j.issn.1673-5374.2012.22.001https://hdl.handle.net/1805/10187en-USAttribution-NonCommercial-NoDerivs 3.0 United StatesSpinal cord injurySchwann cellsBreaking news in spinal cord injury research: FDA approved phase I clinical trial of human, autologous schwann cell transplantation in patients with spinal cord injuriesArticle